{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:15:03Z","timestamp":1790813703794,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T00:00:00Z","timestamp":1556064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00855","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T04:27:56Z","timestamp":1556080076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":47,"title":["Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions"],"prefix":"10.3389","volume":"10","author":[{"given":"Suzan","family":"Wetzels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Vanmierlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L. J. M.","family":"Scheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"van Horssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veerle","family":"Somers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper G.","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome J. A.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiaan","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.expneurol.2014.02.006","article-title":"Molecular mechanisms linking neuroinflammation and neurodegeneration in MS","volume":"262","author":"Ellwardt","year":"2014","journal-title":"Exp Neurol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00401-014-1310-2","article-title":"Macrophage subsets and microglia in multiple sclerosis","volume":"128","author":"Bogie","year":"2014","journal-title":"Acta Neuropathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1007\/s00018-008-8059-5","article-title":"Astrocytes in multiple sclerosis: a product of their environment","volume":"65","author":"Nair","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1136\/jnnp-2012-304333","article-title":"Onset of secondary progressive phase and long-term evolution of multiple sclerosis","volume":"85","author":"Scalfari","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1073\/pnas.0831078100","article-title":"Dichloroacetate effects on glucose and lactate oxidation by neurons and astroglia in vitro and on glucose utilization by brain in vivo","volume":"100","author":"Itoh","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"819202","DOI":"10.1155\/2012\/819202","article-title":"Glyoxal formation and its role in endogenous oxalate synthesis","volume":"2012","author":"Lange","year":"2012","journal-title":"Adv Urol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3389\/fnins.2015.00023","article-title":"Methylglyoxal, the dark side of glycolysis","volume":"9","author":"Allaman","year":"2015","journal-title":"Front Neurosci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/MOL.0b013e32835aea13","article-title":"Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity","volume":"24","author":"Gaens","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1042\/CS20140683","article-title":"The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases","volume":"128","author":"Maessen","year":"2015","journal-title":"Clin Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/ATVBAHA.113.302281","article-title":"Nepsilon-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance","volume":"34","author":"Gaens","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00125-013-2919-8","article-title":"The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1","volume":"56","author":"van Eupen","year":"2013","journal-title":"Diabetologia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1093\/eurheartj\/eht402","article-title":"Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype","volume":"35","author":"Hanssen","year":"2014","journal-title":"Eur Heart J"},{"key":"B18","first-page":"523","article-title":"Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats","volume":"150","author":"Stitt","year":"1997","journal-title":"Am J Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/01.jnen.0000179050.54522.5a","article-title":"Evidence of oxidative stress in the neocortex in incidental Lewy body disease","volume":"64","author":"Dalfo","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1471-4159.2004.02864.x","article-title":"Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment","volume":"92","author":"Ahmed","year":"2005","journal-title":"J Neurochem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/08820139.2010.532267","article-title":"AGE-RAGE in multiple sclerosis brain","volume":"40","author":"Sternberg","year":"2011","journal-title":"Immunol Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1742-2094-7-72","article-title":"Diagnostic potential of plasma carboxymethyllysine and carboxyethyllysine in multiple sclerosis","volume":"7","author":"Sternberg","year":"2010","journal-title":"J Neuroinflammation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"E1311","DOI":"10.3390\/ijms19051311","article-title":"Advanced glycation endproducts are increased in the animal model of multiple sclerosis but cannot be reduced by pyridoxamine treatment or glyoxalase 1 overexpression","volume":"19","author":"Wetzels","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"E1369","DOI":"10.1210\/jc.2013-1068","article-title":"Plasma levels of advanced glycation endproducts Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: the hoorn and CODAM studies","volume":"98","author":"Hanssen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1515\/cclm-2012-0878","article-title":"Quantification of glyoxal, methylglyoxal and 3-deoxyglucosone in blood and plasma by ultra performance liquid chromatography tandem mass spectrometry: evaluation of blood specimen","volume":"52","author":"Scheijen","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1006\/abio.1993.1229","article-title":"The assay of S-D-lactoylglutathione in biological systems","volume":"211","author":"McLellan","year":"1993","journal-title":"Anal Biochem"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1007\/s12035-015-9336-6","article-title":"S100B as a potential biomarker and therapeutic target in multiple sclerosis","volume":"53","author":"Barateiro","year":"2016","journal-title":"Mol Neurobiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1007\/s00125-009-1458-9","article-title":"Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soilin inflammation, immune responses and diabetes mellitus and its complications","volume":"52","author":"Bierhaus","year":"2009","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.molmed.2013.08.001","article-title":"Nuclear factor kappa B (NF-kappaB) in multiple sclerosis pathology","volume":"19","author":"Mc Guire","year":"2013","journal-title":"Trends Mol Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1155\/2008\/824640","article-title":"Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-kappaB as a biomarker for relapse of multiple sclerosis","volume":"25","author":"Satoh","year":"2008","journal-title":"Dis Markers"},{"key":"B31","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2119\/molmed.2010.00071","article-title":"Gene expression changes in multiple sclerosis relapse suggest activation of T and non-T cells","volume":"17","author":"Lindsey","year":"2011","journal-title":"Mol Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1152\/physrev.00004.2013","article-title":"Cerebrospinal fluid secretion by the choroid plexus","volume":"93","author":"Damkier","year":"2013","journal-title":"Physiol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"C673","DOI":"10.1152\/ajpcell.00041.2017","article-title":"Transport across the choroid plexus epithelium","volume":"312","author":"Praetorius","year":"2017","journal-title":"Am J Physiol Cell Physiol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nbd.2016.08.011","article-title":"The choroid plexus in health and in disease: dialogues into and out of the brain","volume":"107","author":"Marques","year":"2017","journal-title":"Neurobiol Dis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","article-title":"CSF, blood-brain barrier, and brain drug delivery","volume":"13","author":"Pardridge","year":"2016","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00855\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T04:27:59Z","timestamp":1556080079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00855\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,24]]},"references-count":36,"alternative-id":["10.3389\/fimmu.2019.00855"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00855","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,24]]},"article-number":"855"}}